Not an actual patient.
Not an actual patient.Sign up for updates about CARVYKTI®
Get helpful information and resources tailored to your needs.
Not an actual patient.Not an actual patient.PATIENT RESOURCES
Traveling away from home for
medical care can be financially and
logistically challenging. Support is
available for eligible patients and
their care partners.
The MyCARVYKTI® Patient Support Program
Patients prescribed CARVYKTI® may be eligible for the MyCARVYKTI® Patient Support Program sponsored by Johnson & Johnson and Legend Biotech. MyCARVYKTI® is designed to support eligible patients and their care partner(s) with travel-related expenses during CARVYKTI® treatment at an Activated Treatment Center. The program may offer support with Transportation, Lodging and Meals, and Out-Of-Pocket Expenses. You may receive this support for leukapheresis, infusion, and bridging therapy if administered at the Activated Treatment Center. To participate in MyCARVYKTI®, you must have been prescribed CARVYKTI® and meet distance and income eligibility criteria. Participants must reside in the United States and its territories.
MyCARVYKTI® may provide assistance with ground or air transportation costs to and from the CARVYKTI® Activated Treatment Center for each approved treatment trip. Transportation support may include mileage reimbursement, bus, rail, or air travel.
MyCARVYKTI® may cover the cost of lodging accommodations near the Activated Treatment Center. All arrangements will be made by the MyCARVYKTI® travel provider. Travel support is available 24/7, 365 days a year, to support eligible patients and their care partner(s).
MyCARVYKTI® may reimburse a daily per diem for costs related to meals and other out-of-pocket travel expenses for approved trips related to CARVYKTI® treatment.
SUPPORT MATERIALS FOR PEOPLE CONSIDERING OR BEING TREATED WITH CARVYKTI®
Choose your language:
English
Download View Link
MyCARVYKTI® Patient Brochure
Find out more about the program designed to support you during CARVYKTI® treatment.
CARVYKTI® Patient Brochure
Learn about how CARVYKTI® works and what to expect during treatment
CARVYKTI® Patient Milestone Guidebook
This guidebook contains information about the treatment as well as resources to assist you with questions about the process
Monitoring for Signs & Symptoms of Potential Side Effects
Learn more about monitoring for signs and symptoms of potential side effects
CARE PARTNERS
Being a care partner can be challenging. It's normal to feel nervous or overwhelmed about what is expected of you. And your role can evolve as the needs of the person you care for change. By supporting a friend or family member receiving CARVYKTI®, you can have a positive impact on their journey during their CARVYKTI® treatment.
Here are a few different ways you can help the person you care for:
Drive them to appointments
After receiving CARVYKTI®, the person you care for should not drive or operate heavy machinery for 2 weeks. They may need to be, or appreciate being, driven to appointments prior to their infusion as well.
Take notes during doctor visits
The person you care for may be unable to fully understand or remember all that they hear during appointments. Having someone for support and to take notes can be very beneficial.
Provide encouragement and support
Treating multiple myeloma can be challenging. You can help them with some of their potential daily struggles like eating right or dealing with certain emotions.
There's no way to anticipate everything you'll need to know as a care partner, but by becoming familiar with the disease and treatment, you can offer support to help the person you care for make informed decisions.
CARE PARTNER RESOURCES
After the person you care for receives their infusion of CARVYKTI®, you will need to stay with them for at least 2 weeks to help them to appointments and to monitor side effects. If you notice that the person you care for is having any reaction to the treatment, contact the doctor or the Activated Treatment Center right away.
RESOURCE MATERIALS
Choose your language:
English
Download View Link
MyCARVYKTI® Patient Brochure
Find out more about the program designed to support people prescribed CARVYKTI® and their care partner(s) during treatment.
CARVYKTI® Post-Infusion Monitoring Guide
A guide to caring for someone after a CARVYKTI® infusion
CARVYKTI® is covered for eligible patients across a variety of insurance providers.
- Commercial and private insurance coverage varies from plan to plan. Coverage is determined on a case-by-case basis by most commercial plans
- Medicare may cover CAR-T therapies when treatment is provided at a healthcare facility in accordance with approved FDA guidance for use
Your healthcare team will work with you and your insurance provider to secure your treatment coverage during the consultation phase prior to beginning the CARVYKTI® treatment process. If you have any questions or concerns about your healthcare coverage benefits, contact your insurance provider.
Some sample questions you may ask your insurance provider could include:
For prior authorization
- I understand that the certified healthcare facility where I'll be receiving CARVYKTI® will be working on receiving the prior authorization from my insurance provider. What can I do to help expedite the process?
- Are there any additional documents that are required from me or my doctor to ensure my treatment with CARVYKTI® is authorized? How do I obtain those documents?
For Medicare
- I am unsure about what Medicare does and does not cover. Is CARVYKTI® covered?
- I have original Medicare and supplemental coverage. Who coordinates the coverage between them for my treatment with CARVYKTI®?
For commercial or private insurance
- I am unsure about what my insurance does and does not cover. Is CARVYKTI® covered?
- Will I be responsible for any copays or deductibles?
The organizations listed here are independent from Janssen Biotech, Inc., and Legend Biotech, and this list is subject to change. This information is provided as a resource for patients and their Care Partners, and is not an endorsement or guarantee of assistance.
Clicking on any of the links below will take you to an online service, the content for which Janssen Biotech, Inc., is not responsible and to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every online service you visit.
The American Cancer Societyhttps://www.cancer.org/cancer/multiple-myeloma.html
CancerCarehttps://www.cancercare.org
Cancer Support Communityhttps://www.cancersupportcommunity.org
HealthTree Foundationhttps://www.healthtree.org
International Myeloma Foundationhttps://www.myeloma.org
The Leukemia and Lymphoma Societywww.LLS.org/PatientSupport
Multiple Myeloma Research Foundationhttps://themmrf.org
Myeloma Coaches Offer Care Partner Supporthttps://www.myelomacrowd.org/Care Partner-coaching
The Leukemia and Lymphoma Societyhttps://www.lls.org/support-resources/Care Partner-support
International Myeloma Foundationhttps://www.myeloma.org/resources-support/caregivers-or-care-partners-myeloma-patients